Cover Image

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis

Saved in:

Bibliographic Details
Main Authors:	Matthew D. Vesely, MD, PhD (Author), Suguru Imaeda, MD (Author), Brett A. King, MD, PhD (Author)
Format:	Book
Published:	Elsevier, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib
by: Zhong J, et al.
Published: (2024)

Successful treatment of refractory IgA vasculitis with tofacitinib
by: Yi-Fei Xu, MD, et al.
Published: (2022)

Chronic actinic dermatitis as a diagnostic clue for adult T-cell leukemia/lymphoma
by: Sakiho Inayoshi, MD, et al.
Published: (2025)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
by: Ronan Talty, BS, et al.
Published: (2022)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)

Oral tofacitinib citrate for recalcitrant cutaneous lupus
by: Evelyne Bonnardeaux, MD, et al.
Published: (2022)

Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
by: Di Lernia V, et al.
Published: (2016)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?
by: Samantha Howland, MPharm, et al.
Published: (2021)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
by: Jonathan J. Park, PhD, et al.
Published: (2023)

Strontium citrate associated drug reaction with eosinophilia and systemic symptoms syndrome with granulomatous dermatitis
by: Elysha Kolitz, BA, et al.
Published: (2021)

Merkel cell carcinoma associated with tofacitinib therapy
by: Luke S. Wallis, MD, et al.
Published: (2021)

Refractory eczematous dermatitis arising after allogeneic hematopoietic stem cell transplantation responsive to dupilumab
by: Jenny Lai, PhD, et al.
Published: (2024)

Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
by: Mariam Alam, MD, et al.
Published: (2021)

Release of cervical muscular tension improved severe pruritus in moderate-to-severe atopic dermatitis: A case series
by: Shusaku Hosono, MD, et al.
Published: (2020)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)

Severe atopic dermatitis with cutis laxa caused by a variant in the ELN gene
by: Tatsuya Katsumi, MD, et al.
Published: (2024)

Intravenous immunoglobulin-refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
by: Neda Shahriari, MD, et al.
Published: (2023)

Association between endometrial thickness before ovulation, live birth, and placenta previa rates in clomiphene citrate-treated cyclesAJOG Global Reports at a Glance
by: Shogo Nishii, MD, PhD, et al.
Published: (2023)

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
by: Dafna D. Gladman, MD, et al.
Published: (2020)

Novel mevalonate kinase missense mutation in a patient with disseminated superficial actinic porokeratosis
by: George D. Glinos, BS, et al.
Published: (2018)

Refractory rheumatoid vasculitis complicated by cytomegalovirus reactivation as a manifestation of immune reconstitution inflammatory syndrome
by: Michie Katsuta, MD, PhD, et al.
Published: (2020)

Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine
by: Rasool Choopani MD, PhD, et al.
Published: (2017)

Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine
by: Rasool Choopani MD, PhD, et al.
Published: (2017)

Successful treatment of refractory folliculitis decalvans with apremilast
by: Mirjam Fässler, MD, et al.
Published: (2020)

Effects of disease severity on sleep and quality of life in Taiwanese patients with atopic dermatitis
by: Pei-Yun Ho, MD, et al.
Published: (2022)

Real-World Efficacy and Safety of Oral Tofacitinib in Patients with Refractory Moderate to Severe Atopic Dermatitis: A Multicenter Retrospective Study
by: Sandipan Dhar, et al.
Published: (2024)

Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient
by: Danielle M. Peterson, MD, et al.
Published: (2020)

Treatment of cutaneous lupus with topical ruxolitinib cream
by: Jonathan J. Park, PhD, et al.
Published: (2022)

The role of antihistamines in chronic actinic dermatitis treatment
by: E. V. Orlov, et al.
Published: (2017)

Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020)

Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial
by: Takeo Odaka, MD, PhD, et al.
Published: (2017)

Anifrolumab for the treatment of refractory chilblain lupus erythematosus
by: Michael J. Woodbury, BS, et al.
Published: (2024)

Correlation between anxiety and depression risk and atopic dermatitis severity in Taiwan: A cross-sectional studyCapsule Summary
by: Chia-Jung Hsu, MD, et al.
Published: (2022)

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
by: Danielle M. Peterson, MD, et al.
Published: (2022)

Resolution of refractory generalized granuloma annulare after treatment with alitretinoin
by: Jun Hyo Lee, MD, et al.
Published: (2022)